B7 family molecules: Novel immunomodulators at the maternal-fetal interface

M. G. Petroff, L. Chen, T. A. Phillips, J. S. Hunt

Research output: Contribution to journalArticle

Abstract

The placenta utilizes both active and passive mechanisms to evade rejection by the maternal immune system. Recently, the mRNA for two newly cloned members of the B7 family of immunomodulatory cell-associated proteins have been identified in the human term placenta. In this article, we review the current knowledge of the B7 family member B7-H1, and discuss how it may participate in modulation of the maternal immune system at the maternal-fetal interface. B7-H1 has been found to possess immunostimulatory or immuno inhibitory properties, and immunohistological examination of first trimester and term placenta has revealed that this protein is abundant in the placenta. B7-H1 is highly expressed by both the syncytiotrophoblast and extravillous cytotrophoblast, both of which lie in direct contact with maternal blood and tissue. Further, treatment of the choriocarcinoma cell line, JEG-3, with recombinant human interferon (IFN)-γ resulted in a dose-dependent increase in the abundance of the message for B7-H1, suggesting that IFN-γ could regulate expression of B7-H1 by the trophoblast. These studies document that the positioning of B7-H1 at the maternal-fetal interface is such that it could participate in suppression of activated maternal leukocytes.

Original languageEnglish (US)
JournalPlacenta
Volume23
Issue numberSUPPL. 1
DOIs
StatePublished - Apr 2002
Externally publishedYes

Fingerprint

B7 Antigens
Immunologic Factors
Mothers
Placenta
Trophoblasts
Interferons
Immune System
Choriocarcinoma
First Pregnancy Trimester
Proteins
Leukocytes
Cell Line
Messenger RNA

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Petroff, M. G., Chen, L., Phillips, T. A., & Hunt, J. S. (2002). B7 family molecules: Novel immunomodulators at the maternal-fetal interface. Placenta, 23(SUPPL. 1). https://doi.org/10.1053/plac.2002.0813

B7 family molecules : Novel immunomodulators at the maternal-fetal interface. / Petroff, M. G.; Chen, L.; Phillips, T. A.; Hunt, J. S.

In: Placenta, Vol. 23, No. SUPPL. 1, 04.2002.

Research output: Contribution to journalArticle

Petroff, MG, Chen, L, Phillips, TA & Hunt, JS 2002, 'B7 family molecules: Novel immunomodulators at the maternal-fetal interface', Placenta, vol. 23, no. SUPPL. 1. https://doi.org/10.1053/plac.2002.0813
Petroff, M. G. ; Chen, L. ; Phillips, T. A. ; Hunt, J. S. / B7 family molecules : Novel immunomodulators at the maternal-fetal interface. In: Placenta. 2002 ; Vol. 23, No. SUPPL. 1.
@article{2ab533565a23425bba7fe6676ccd179d,
title = "B7 family molecules: Novel immunomodulators at the maternal-fetal interface",
abstract = "The placenta utilizes both active and passive mechanisms to evade rejection by the maternal immune system. Recently, the mRNA for two newly cloned members of the B7 family of immunomodulatory cell-associated proteins have been identified in the human term placenta. In this article, we review the current knowledge of the B7 family member B7-H1, and discuss how it may participate in modulation of the maternal immune system at the maternal-fetal interface. B7-H1 has been found to possess immunostimulatory or immuno inhibitory properties, and immunohistological examination of first trimester and term placenta has revealed that this protein is abundant in the placenta. B7-H1 is highly expressed by both the syncytiotrophoblast and extravillous cytotrophoblast, both of which lie in direct contact with maternal blood and tissue. Further, treatment of the choriocarcinoma cell line, JEG-3, with recombinant human interferon (IFN)-γ resulted in a dose-dependent increase in the abundance of the message for B7-H1, suggesting that IFN-γ could regulate expression of B7-H1 by the trophoblast. These studies document that the positioning of B7-H1 at the maternal-fetal interface is such that it could participate in suppression of activated maternal leukocytes.",
author = "Petroff, {M. G.} and L. Chen and Phillips, {T. A.} and Hunt, {J. S.}",
year = "2002",
month = "4",
doi = "10.1053/plac.2002.0813",
language = "English (US)",
volume = "23",
journal = "Placenta",
issn = "0143-4004",
publisher = "W.B. Saunders Ltd",
number = "SUPPL. 1",

}

TY - JOUR

T1 - B7 family molecules

T2 - Novel immunomodulators at the maternal-fetal interface

AU - Petroff, M. G.

AU - Chen, L.

AU - Phillips, T. A.

AU - Hunt, J. S.

PY - 2002/4

Y1 - 2002/4

N2 - The placenta utilizes both active and passive mechanisms to evade rejection by the maternal immune system. Recently, the mRNA for two newly cloned members of the B7 family of immunomodulatory cell-associated proteins have been identified in the human term placenta. In this article, we review the current knowledge of the B7 family member B7-H1, and discuss how it may participate in modulation of the maternal immune system at the maternal-fetal interface. B7-H1 has been found to possess immunostimulatory or immuno inhibitory properties, and immunohistological examination of first trimester and term placenta has revealed that this protein is abundant in the placenta. B7-H1 is highly expressed by both the syncytiotrophoblast and extravillous cytotrophoblast, both of which lie in direct contact with maternal blood and tissue. Further, treatment of the choriocarcinoma cell line, JEG-3, with recombinant human interferon (IFN)-γ resulted in a dose-dependent increase in the abundance of the message for B7-H1, suggesting that IFN-γ could regulate expression of B7-H1 by the trophoblast. These studies document that the positioning of B7-H1 at the maternal-fetal interface is such that it could participate in suppression of activated maternal leukocytes.

AB - The placenta utilizes both active and passive mechanisms to evade rejection by the maternal immune system. Recently, the mRNA for two newly cloned members of the B7 family of immunomodulatory cell-associated proteins have been identified in the human term placenta. In this article, we review the current knowledge of the B7 family member B7-H1, and discuss how it may participate in modulation of the maternal immune system at the maternal-fetal interface. B7-H1 has been found to possess immunostimulatory or immuno inhibitory properties, and immunohistological examination of first trimester and term placenta has revealed that this protein is abundant in the placenta. B7-H1 is highly expressed by both the syncytiotrophoblast and extravillous cytotrophoblast, both of which lie in direct contact with maternal blood and tissue. Further, treatment of the choriocarcinoma cell line, JEG-3, with recombinant human interferon (IFN)-γ resulted in a dose-dependent increase in the abundance of the message for B7-H1, suggesting that IFN-γ could regulate expression of B7-H1 by the trophoblast. These studies document that the positioning of B7-H1 at the maternal-fetal interface is such that it could participate in suppression of activated maternal leukocytes.

UR - http://www.scopus.com/inward/record.url?scp=3142728923&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3142728923&partnerID=8YFLogxK

U2 - 10.1053/plac.2002.0813

DO - 10.1053/plac.2002.0813

M3 - Article

C2 - 11978065

AN - SCOPUS:3142728923

VL - 23

JO - Placenta

JF - Placenta

SN - 0143-4004

IS - SUPPL. 1

ER -